Next Science Past Earnings Performance
Past criteria checks 0/6
Next Science has been growing earnings at an average annual rate of 1%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 40.4% per year.
Key information
1.0%
Earnings growth rate
13.2%
EPS growth rate
Medical Equipment Industry Growth | 5.8% |
Revenue growth rate | 40.4% |
Return on equity | -126.9% |
Net Margin | -73.4% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Next Science makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 22 | -16 | 26 | 6 |
30 Sep 23 | 19 | -15 | 23 | 6 |
30 Jun 23 | 16 | -15 | 19 | 7 |
31 Mar 23 | 14 | -14 | 18 | 6 |
31 Dec 22 | 12 | -13 | 16 | 6 |
30 Sep 22 | 11 | -12 | 15 | 6 |
30 Jun 22 | 10 | -12 | 15 | 6 |
31 Mar 22 | 10 | -11 | 13 | 5 |
31 Dec 21 | 9 | -9 | 12 | 5 |
30 Sep 21 | 8 | -9 | 10 | 5 |
30 Jun 21 | 6 | -9 | 9 | 6 |
31 Mar 21 | 5 | -11 | 9 | 6 |
31 Dec 20 | 3 | -12 | 9 | 6 |
30 Sep 20 | 3 | -12 | 8 | 7 |
30 Jun 20 | 3 | -13 | 8 | 8 |
31 Mar 20 | 3 | -13 | 9 | 6 |
31 Dec 19 | 4 | -14 | 11 | 5 |
30 Sep 19 | 4 | -15 | 13 | 3 |
30 Jun 19 | 4 | -16 | 16 | 2 |
31 Mar 19 | 4 | -15 | 15 | 1 |
31 Dec 18 | 3 | -14 | 15 | 1 |
31 Dec 17 | 4 | -2 | 6 | 1 |
31 Dec 16 | 1 | -3 | 3 | 1 |
Quality Earnings: NXS is currently unprofitable.
Growing Profit Margin: NXS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NXS is unprofitable, but has reduced losses over the past 5 years at a rate of 1% per year.
Accelerating Growth: Unable to compare NXS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NXS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: NXS has a negative Return on Equity (-126.91%), as it is currently unprofitable.